Fruchtman Steven M 4
4 · Onconova Therapeutics, Inc. · Filed Aug 4, 2023
Insider Transaction Report
Form 4
Fruchtman Steven M
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2023-08-02+12,567→ 53,044 total - Tax Payment
Common Stock
2023-08-03$1.01/sh−4,744$4,791→ 48,300 total - Exercise/Conversion
Restricted Stock Units
2023-08-02−12,567→ 12,567 total→ Common Stock (12,567 underlying)
Footnotes (2)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]On August 2, 2021 the reporting person was granted 37,700 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary.